Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK_1 Receptor
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Pharmacological Societyの論文
- 2008-01-20
著者
-
Watanabe Yumi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Taniguchi Hiroyuki
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
OKAMOTO Masahito
Sales & Marketing Division, Mitsubishi Tanabe Pharma Corporation
-
ISHII Taketoshi
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
NAGASAKI Masaaki
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
SAITO Akira
Research Strategy & Planning, Mitsubishi Tanabe Pharma Corporation
-
ASAI Hidetoshi
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
KIUCHI Satoko
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
Taniguchi Hiroyuki
Pharmacological Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Kiuchi Satoko
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Asai Hidetoshi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Asai Hidetoshi
Pharmaceutical Development Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Ishii Taketoshi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Ishii Taketoshi
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Nagasaki M
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Okamoto Masahito
Sales & Marketing Division Mitsubishi Tanabe Pharma Corporation
-
Nagasaki Masaaki
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Saito Akira
Research Strategy & Planning Mitsubishi Tanabe Pharma Corporation
-
Watanabe Yumi
Pharmacology Department, Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Nagasaki Masaaki
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd.
関連論文
- Long-Lasting Anti-emetic Effect of T-2328, a Novel NK_1 Antagonist
- Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK_1 Receptor
- Effects of Cholecystokinin (CCK)-JMV-180 on the CCK Receptors of Rabbit Pancreatic Acini and Gallbladder Smooth Muscle
- Focal Cerebral Ischemia-Induced Escape Deficit in Rats Is Ameliorated by a Reversible Inhibitor of Monoamine Oxidase-A : Implications for a Novel Animal Model of Post-Stroke Depression
- Possible Therapeutic Effect of T-794,a Novel Reversible Inhibitor of Monoamine Oxidase-A, on Post-Stroke Emotional Disturbances, Assessed in Animal Models of Depression
- Metabolic Abnormalities Caused by 3-Acetylpyridine in the Cerebral Motor Regions of Rats: Partial Recovery by Thyrotropin-Releasing Hormone
- A Novel Na^+ and Ca^ Channel Blocker, T-477, Prevents Brain Edema Following Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Time-Dependent Changes in the Ischemic Forebrain Following the Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Anti-apoptotic Effect of Acetyl-l-carnitine and l-Carnitine in Primary Cultured Neurons
- Pharmacological Characterization of T-2328, 2-Fluoro-4-methoxy-3-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK1 Receptor
- Effect of Trimebutine on Contractile Responses in Skinned Ileal Smooth Muscle.